NYSE:HCA
HCA Healthcare, Inc.
A dominant US hospital operator with accelerating revenue growth and a strong balance sheet fueled by robust free cash flow generation.
Key Metrics
Investment Thesis
Bull Case
Investors should consider HCA as a stable defensive play given its essential service nature and consistent double-digit revenue growth trajectory from $60B in 2022 to over $75B in 2025. The company's aggressive capital allocation strategy, evidenced by large share repurchases of $10.07B, supports shareholder value creation while maintaining a dominant market position. High operating margins and the recurring revenue model of hospital services offer resilience against economic downturns.
Bear Case
Potential buyers should be wary of the company's negative shareholders equity of -$2.77B, which indicates high leverage typical but risky for this sector. Dependence on government reimbursements exposes earnings to political shifts that could reduce payment rates below cost structures. The heavy reliance on debt financing means interest rate hikes directly impact profitability, as seen with $2.25B in interest expense.
About HCA Healthcare, Inc.
HCA Healthcare Inc. is a leading provider of healthcare services operating more than 180 hospitals and nearly 900 critical access and outpatient facilities across the United States. The company serves diverse markets ranging from acute care to long-term post-acute services, generating over $75 billion in annual revenue. Its extensive network allows it to deliver comprehensive patient care while maintaining operational efficiency through significant capital investments.
Analysis
Management Discussion
Financial performance in 2025 demonstrates strong recovery with net profit reaching $7.78B, a significant increase from prior years. Operating cash flow of $12.64B highlights robust liquidity generation, allowing the company to fund $4.94B in capital expenditures and return capital via dividends and share repurchases. While total liabilities exceed assets due to the leverage-heavy nature of healthcare operations, the strong operating cash flow provides a solid buffer for debt servicing.
Industry Overview
The US hospital services industry is characterized by high barriers to entry and a shift towards value-based care models that reward efficiency and quality outcomes. Consolidation remains a trend as larger operators seek scale to negotiate better rates with payers and absorb fixed cost structures. Technological advancements in telehealth and electronic health records are becoming standard requirements for maintaining competitive relevance.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $60.23B | $64.97B | $70.60B | $75.60B |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $60.23B | $64.97B | $70.60B | $75.60B |
| Operating Expenses | $51.65B | $57.26B | $62.08B | $65.77B |
| Operating Income | $8.58B | $7.71B | $8.52B | $9.83B |
| G&A | $378.0M | $315.0M | $421.0M | $548.0M |
| Stock-Based Comp | $341.0M | $262.0M | $360.0M | $401.0M |
| D&A | $2.97B | $3.08B | $3.31B | $3.52B |
| Depreciation | $2.94B | $3.05B | $3.29B | $3.51B |
| Amortization | $44.0M | $20.0M | $16.0M | $12.0M |
| Other OpEx | $51.27B | $56.95B | $61.66B | $65.22B |
| Non-Operating Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1.74B | $1.94B | $2.06B | $2.25B |
| Pre-Tax Income | $8.58B | $7.71B | $8.52B | $9.83B |
| Income Tax | $1.75B | $1.61B | $1.87B | $2.05B |
| Continuing Ops | $6.83B | $6.09B | $6.66B | $7.78B |
| Discontinued Ops | $0 | $0 | $0 | $0 |
| Net Income | $6.83B | $6.09B | $6.66B | $7.78B |
| Minority Interest | $1.19B | $849.0M | $897.0M | $998.0M |
| Net to Common | $5.64B | $5.24B | $5.76B | $6.78B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current Assets | $13.64B | $14.93B | $16.41B | $15.78B |
| Cash & Equivalents | $908.0M | $935.0M | $1.93B | $1.04B |
| Accounts Receivable | $8.89B | $9.96B | $10.75B | $10.87B |
| Inventory | $2.07B | $2.02B | $1.74B | $1.65B |
| Other Current Assets | $1.78B | $2.01B | $1.99B | $2.22B |
| Long-Term Assets | $38.80B | $41.28B | $43.10B | $44.94B |
| PP&E (Net) | $25.57B | $27.71B | $29.41B | $31.14B |
| Operating Leases | $2.06B | $2.21B | $2.13B | $2.13B |
| LT Investments | — | $477.0M | $569.0M | $485.0M |
| Other LT Assets | $10.33B | $10.13B | $10.32B | $10.55B |
| Total Assets | $52.44B | $56.21B | $59.51B | $60.72B |
| Current Liabilities | $9.90B | $12.65B | $15.18B | $16.35B |
| Accounts Payable | $4.24B | $4.23B | $4.28B | $4.66B |
| Current Debt | $370.0M | $2.42B | $4.70B | — |
| Current Leases | $364.0M | $363.0M | $343.0M | $352.0M |
| Other Current Liab | $4.93B | $5.63B | $5.86B | $11.34B |
| Long-Term Liabilities | $42.61B | $42.50B | $43.78B | $47.14B |
| Long-Term Debt | $37.71B | $37.17B | $38.33B | $41.60B |
| LT Operating Leases | $1.75B | $1.90B | $1.86B | $1.85B |
| Other LT Liab | $3.14B | $3.42B | $3.58B | $3.69B |
| Total Liabilities | $52.51B | $55.15B | $58.96B | $63.49B |
| Shareholders' Equity | $-73.0M | $1.06B | $555.0M | $-2.77B |
| Retained Earnings | $-2.28B | $-1.35B | $-2.12B | $-5.72B |
| AOCI | $-490.0M | $-425.0M | $-387.0M | $-305.0M |
| Total L&E | $52.44B | $56.21B | $59.51B | $60.72B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $6.83B | $6.09B | $6.66B | $7.78B |
| Non-Cash Adjustments | $1.13B | $1.68B | $3.03B | $3.94B |
| Working Capital Changes | $560.0M | $1.67B | $824.0M | $914.0M |
| Cash from Operations | $8.52B | $9.43B | $10.51B | $12.64B |
| Capital Expenditures | $4.39B | $4.74B | $4.88B | $4.94B |
| Cash from Investing | $-3.39B | $-5.32B | $-4.93B | $-4.99B |
| Debt Issuances | $6.00B | $3.22B | $7.50B | $8.47B |
| Debt Repayments | $2.83B | $909.0M | $2.41B | $7.39B |
| Share Buybacks | $7.00B | $3.81B | $6.04B | $10.07B |
| Dividends Paid | $653.0M | $661.0M | $690.0M | $679.0M |
| Cash from Financing | $-5.66B | $-4.09B | $-4.58B | $-8.55B |
| FX Effect | $-20.0M | $7.0M | $-1.0M | $9.0M |
| Net Change in Cash | $-543.0M | $27.0M | $998.0M | $-893.0M |
| Beginning Cash | $1.45B | $908.0M | $935.0M | $1.93B |
| Ending Cash | $908.0M | $935.0M | $1.93B | $1.04B |
Frequently Asked Questions
How does HCA Healthcare, Inc. make money?
Revenue is driven primarily by acute care hospitals which form the core of its footprint, complemented by long-term post-acute services including rehabilitation and skilled nursing facilities. The company also generates income through ambulatory surgery centers and physician groups that feed directly into its hospital networks, creating an integrated care ecosystem.
What are the main risks for HCA?
The healthcare sector faces persistent regulatory headwinds including potential government price controls and labor legislation impacting wage growth. Rising operational costs related to staffing shortages and medical inflation could compress margins despite revenue growth. Prolonged interest rate volatility increases borrowing costs for the company's substantial long-term debt load, affecting net income.
What is HCA's competitive advantage?
HCA possesses one of the largest private hospital footprints in the nation, providing unparalleled economies of scale and purchasing power for supplies and labor. Its highly experienced management team operates with a decentralized model that empowers individual facilities to adapt quickly to local market demands. The company's ability to consistently reinvest billions in capital expenditures ensures continuous modernization of its facility infrastructure.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.